BE781979A - Nouveaux derives de prostaglandines, leur preparation, et compositions pharmaceutiques les contenant - Google Patents

Nouveaux derives de prostaglandines, leur preparation, et compositions pharmaceutiques les contenant

Info

Publication number
BE781979A
BE781979A BE781979A BE781979A BE781979A BE 781979 A BE781979 A BE 781979A BE 781979 A BE781979 A BE 781979A BE 781979 A BE781979 A BE 781979A BE 781979 A BE781979 A BE 781979A
Authority
BE
Belgium
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
prostaglandin derivatives
new prostaglandin
Prior art date
Application number
BE781979A
Other languages
English (en)
French (fr)
Inventor
B J Magerlein
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE781979A publication Critical patent/BE781979A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
BE781979A 1971-04-12 1972-04-12 Nouveaux derives de prostaglandines, leur preparation, et compositions pharmaceutiques les contenant BE781979A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13334271A 1971-04-12 1971-04-12
US05/555,780 US4212811A (en) 1971-04-12 1975-03-06 Bicyclic lactone intermediates

Publications (1)

Publication Number Publication Date
BE781979A true BE781979A (fr) 1972-10-12

Family

ID=26831285

Family Applications (1)

Application Number Title Priority Date Filing Date
BE781979A BE781979A (fr) 1971-04-12 1972-04-12 Nouveaux derives de prostaglandines, leur preparation, et compositions pharmaceutiques les contenant

Country Status (10)

Country Link
US (1) US4212811A (en, 2012)
JP (2) JPS5069063A (en, 2012)
BE (1) BE781979A (en, 2012)
CA (1) CA984387A (en, 2012)
CH (2) CH573384A5 (en, 2012)
DE (1) DE2217044C2 (en, 2012)
FR (1) FR2132859B1 (en, 2012)
GB (2) GB1392991A (en, 2012)
NL (1) NL163507C (en, 2012)
SE (3) SE401364B (en, 2012)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1060007A (en) * 1975-02-18 1979-08-07 Gilbert A. Youngdale 2a,2b-dihomo-16,16-dimethyl-prostaglandin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (en, 2012) * 1970-06-10 1975-02-04
US3778450A (en) * 1971-03-23 1973-12-11 Upjohn Co Certain bicyclic lactones
US3901923A (en) * 1971-03-23 1975-08-26 Upjohn Co Acylated bicyclic lactones

Also Published As

Publication number Publication date
SE418289B (sv) 1981-05-18
CH573384A5 (en, 2012) 1976-03-15
GB1392991A (en) 1975-05-07
GB1392992A (en) 1975-05-07
JPS5069063A (en, 2012) 1975-06-09
JPS5069050A (en, 2012) 1975-06-09
US4212811A (en) 1980-07-15
SE7506373L (sv) 1975-06-04
NL163507C (nl) 1980-09-15
NL7204869A (en, 2012) 1972-10-16
FR2132859B1 (en, 2012) 1976-04-16
CH573887A5 (en, 2012) 1976-03-31
SE7700095L (sv) 1977-01-05
JPS562063B2 (en, 2012) 1981-01-17
SE401364B (sv) 1978-05-02
FR2132859A1 (en, 2012) 1972-11-24
CA984387A (en) 1976-02-24
DE2217044A1 (de) 1972-10-26
NL163507B (nl) 1980-04-15
DE2217044C2 (de) 1985-07-11
SE401365B (sv) 1978-05-02

Similar Documents

Publication Publication Date Title
BE801108A (fr) Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant
BE789629A (fr) Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
BE778796A (fr) Derives des polymyxines, leur preparation et les compositions medicinales les contenant
BE771493A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsqui les contiennent
BE764659A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE764660A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE746301A (fr) Nouveaux benzylimidazoles alpha, alpha-disubstitues, leur procede de preparation et compositions pharmaceutiques les contenant
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
BE746756A (fr) Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces derives
BE777911A (fr) Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
BE786031A (fr) Nouveaux derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
BE806854A (fr) Nouvelles urees tricycliques, leur preparation et les compositions pharmaceutiques en contenant
BE785398A (fr) Gonadotrophines presentant une activite prolongee, leur preparation et compositions pharmaceutiques les contenant
BE775294A (fr) Nouveaux derives de la pyridazine, leur preparation et medicaments les contenant
BE759842R (fr) Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
BE792079A (fr) Nouveaux composes insatures, leur preparation et leur application commemedicaments
BE781979A (fr) Nouveaux derives de prostaglandines, leur preparation, et compositions pharmaceutiques les contenant
BE765443A (fr) Nouveaux derives de la piperidine, leur preparation et medicaments contenant ces derives
BE761713A (fr) Nouvelles pyrrolidines substituees, leur preparation et compositions pharmaceutiques les contenant
BE776315A (fr) Nouveaux derives de la 1-amino-isoquinoleine, leur preparation et leur application comme medicaments
BE781013A (fr) Nouveaux derives de la quinoleine, leur preparation et leur applicationcomme medicaments
BE767670A (fr) Nouveaux derives d'imidazolium, leur preparation et compositions en contenant
BE753068A (fr) Nouveaux derives de la furanone, leur preparation et medicaments contenant ces derives
BE791678A (fr) Nouveaux derives de decahydroquinoleinol, leur procede de preparation ainsi que les compositions therapeutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19860430